R. Laskawi/S. Rohrbach: Surgical and Conservative Methods for Restoring Impaired Motor Function
Hammerschlag PE, Brudny J, Cusuma- 27.
acyclovir and prednisone for Bel ’s pal-
palsy: management of sequelae using 28.
palsy: why I don‘t do it. Eur Arch Otorhi-
Heininger I. Rehabilitation of facial ex-
Schröder M. Hydroxyäthylstärke in der
Beurskens CH, Heymans PG. Positive 29.
of facial paralysis: stiffness, lip mobil-
Adour KK, Ruboyianes JM, Von Doer- 15.
ry CP Jr, Hitchcock T. Bel ‘s palsy treat-
double-blind, randomized, control ed 16.
mimic rehabilitation fol owing removal 31.
facial paralysis. Otolaryngol Clin North
Bachor E, V. Bonkowsky, T. Hacki: Her- 17.
Cohen LG, Bandinel i S, Findley TW, 32.
Otorhinoplaryngol 1996; 253:297-300 18.
Rödel R, Markus H, Tergau F, Laskawi 33. R. Laskawi/S. Rohrbach: Surgical and Conservative Methods for Restoring Impaired Motor Function
Evans DM. Hypoglosso-facial anasto- 60.
Laskawi R: Die Behandlung des Spas- 42.
Br. J. Plast. Surg. 1974; 27: 251-257.
mus facialis mit Botulinum Toxin, in: R.
Falbe-Hansen J, Hermann S. Hypo- 61.
Hitselberger, W. Hypoglossal-facial 62.
per P, Baetz A. Botulinum toxin treat- 44.
nerve anastomosis after acoustic neu- 63.
synkinesis after facial paralysis: treat- 46.
Gulya AJ. Facial reanimation with the 64.
Laskawi R, Rödel R. Möglichkeit der Op-
sia of the depressor anguli oris muscle:
A rare case of congenital lower lip palsy
palsy fol owing surgery for cerebel o- 65.
pieerfolgen bei Fazialisparesen. HNO 49.
for preservation of hypoglossal func- 67.
erte computergestützte Dokumenta- 50.
Laskawi R, El ies M, Rödel R, Schoene- 51.
facial surgery. Clin. Plast. Surg. 1979;
R. Laskawi/S. Rohrbach: Surgical and Conservative Methods for Restoring Impaired Motor Function
Greenwood J. The surgical treatment of 98.
Guntinas-Lichius O. The facial nerve 78.
ic facial spasm. Lancet 1932; 1:657- 99.
of medicine, Vol. 8 ; Al butt C, Rol eston
after surgical management. Curr Opin 79.
rotisation bei Fazialisparese. Zbl. Chir 80.
muscle Transposition. In: the facial 81.
101. Stieda A. Die chirurgische Behandlung
Baker DC, Conley J. Regional muscle 82.
modification of cholinergic balance. 102. Takahashi T, Dohi S. Hemifacial spasm:
Jannetta PJ. Microvascular decom- 103. Wakasugi B. Facial nerve block in the
Sachs ME, Conley J. Intraoral masseter 83.
Johnson J, Tucker HM. Selective rein- 84.
Therapie von Spasmus hemifacialis 105. Fish U. Extracranial surgery for facial
function of the facial nerve. Ann Otol 106. Jones TW, Wal er RR, Samples JR. My-
pedicle technique. Clin Plast Surg 86.
Behandlung des Spasmus facialis. 107. Jannetta PJ. The cause of hemifacial
tion for rehabilitation of the paralysed 87. R. Laskawi/S. Rohrbach: Surgical and Conservative Methods for Restoring Impaired Motor Function
108. Jannetta PJ. Trigeminal neuralgia and 115. Toldi J, Laskawi R, Landgrebe M, Wolff
contol ed trial to evaluate the effects of 131. Meyer CH. Outcome of selective pe-
109. Jannetta PJ. Vascular compression of
the facial nerve at the brainstem in 116. Laskawi R. Zentralnervöse Verän-
tomy in head and neck cancer survi- 132. Braun V, Richter HP. Selective periph-
facialis der Ratte. Med. Habil.-Schrift,
124. Fechner B. Persönliche Mitteilung.
125. Stacy M. Idiopathic cervical dystonia:
an overview. Neurology 200; 55: S2- 133. Chen X, Ma A, Liang J, Ji S, Pei S. Selec-
111. Jannetta PJ, Hackett E, Ruby JR. Elec-
tromyographic and electron micro- 118. Thanos PK, Tiangco DA, Terzis JK. En-
134. Taira T, Hori T. A novel denervation
like growth factor-I (IGF-I) delivery to a
127. Benecke R, Dressler D. Zervikale Dys-
112. Jannetta PJ, Abbasy M, Maroon JC, 119. J
apie im Kopf- Halsbereich. Urban & 135. Loher TJ, Pohle T, Krauss JK. Function-
definitive microsurgical treatment of 120. Tiangco DA, Papakonstantinou KC,
al stereotactic surgery for treatment of
113. Streppel M, Popratiloff A, Gruart A,
treatments in cervical dystonia: pre- 136. Wirth G. Sprachstörungen, Sprech-
gado-Garcia JM, Neiss WF, Stennert E. 121. Werner J. Aktuel er Stand der Versor-
liminary results in four patients. Funct
129. Chandawarkar RY, Cervino L, Penning- 137. Böhme G. Sprach-, Sprech-, Stimm-
ry to the spinal accessory nerve. Plast 138. Pascher W, Bauer H. Differential-
Krankheitsverarbeitung von Patienten 122. Schmidt D, Malin JP: Erkrankungen der
moto JY, Swenson MA, McClel and RL, 139. Laskawi R, Rohrbach S (2001). Oro-
140. Rödel R, Laskawi R. Hypoglossal-Facial
141. Rubin LR, Mishriki JJ, Speace G. Re-
142. Rubin LR. Reanimation of the hemipa-
143. Schneider I, Thumfart WF, Pototschnig
Preparation, physicochemical characterization and biologicalReceived August 26, 2008Accepted March 18, 2009evaluation of cefodizime metal ion complexesSayed H. Audaa,b, Y. Mrestanic, Dietrich H. Niesd, Cornelia GroßedInstitutes of aPharmacy, cApplied Dermatopharmacy and dBiology, Martin-Luther-University Halle-Wittenberg,Halle (Saale), Germany, and bDepartment of Pharmaceutics and Industria
Prime Therapeutics Specialty Pharmacy Drug Management List Reminder About Coverage for Self-Administered Specialty Medications Specialty medications are generally prescribed to treat chronic, complex medical conditions, such as multiple sclerosis, hepatitis C and rheumatoid arthritis. These medications are often received by injection or infusion, require careful adherence to a treatment plan